Skip to content
Friday, October 30, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • What pledges Eisenkot and Netanayhu need to break to become PM October 29, 2026
  • Two years after a judge’s order, a Spanish dictionary still defines ‘Jewish’ as ‘miserly’ October 29, 2026
  • Rabbis of LA | Rabbi Rembaum on Life Without Fredi October 28, 2026
  • Progressive US Jews call for Israel’s opposition bloc to welcome Arab parties October 28, 2026
  • Jewish Floridians chew over the pros and cons of Democratic Senate nominee Angie Nixon October 28, 2026
  • Sacha Baron Cohen wants to fight bigotry. But is Ali G part of the problem? October 28, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.